Atlas Trials

Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

Clinical trial NCT07172347 · RECRUITING

Trial details

NCT number
NCT07172347
Sponsor
Jiangsu vcare pharmaceutical technology co., LTD
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-segmental Vitiligo
Start date
2025-10-31
Primary completion
2027-08-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.